In hepatocellular carcinoma (HCC), the activation of TLR4 and TLR9 by NETs led to upregulation of cyclooxygenase-2 (COX2), which enhanced the invasiveness of tumor cells. The gene discussed is TLR9; the disease is neoplasm.